| Followers | 883 |
| Posts | 304355 |
| Boards Moderated | 5 |
| Alias Born | 06/09/2006 |
Tuesday, September 20, 2016 1:19:24 PM
$RGBP dCellVax
Breast Cancer – dCellVax - IND #16200
CellVax is a dendritic cell based immunotherapy that stimulates the patient’s immune system through a process called “gene silencing.”
10 advanced breast cancer patients
Efficacy endpoints at 6 and 12 months
Establishment of safety will allow for rapid expansion of patient numbers
Currently addressing FDA questions with Dr. Santosh Kesari, head of UCSD Neuro-Oncology program
http://www.regenbiopharmainc.com/product-pipeline.html
Breast Cancer – dCellVax - IND #16200
CellVax is a dendritic cell based immunotherapy that stimulates the patient’s immune system through a process called “gene silencing.”
10 advanced breast cancer patients
Efficacy endpoints at 6 and 12 months
Establishment of safety will allow for rapid expansion of patient numbers
Currently addressing FDA questions with Dr. Santosh Kesari, head of UCSD Neuro-Oncology program
http://www.regenbiopharmainc.com/product-pipeline.html
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
